PROPELLING INDIA'S GLOBAL BULK DRUG TRAJECTORY

A silent player in India's fast evolving pharmaceutical sector Active Pharmaceutical Ingredients no longer remains one of the backroom boys. Steadily but surely, it's a voice that's being heard for the impressive positioning it has achieved as a niche category in this arena.

- 

Dr. Satish Wagh, Founder- Chairman Supriya Lifesciences, a first-generation entrepreneur has been a major protagonist in transforming the global fortunes of India's Bulk Drug segment in the pharma business. Supriya Lifesciences, born in 1987 out of his decades-long experiences in pharmaceutical manufacturing, today manufactures over 40 Active Pharmaceutical Ingredients serving 2,000+ customers across 120 countries.

At the time when Dr. Wagh made his entry in the pharma industry, India's Bulk Drug industry was relegated to the bottom tier of global supply chains—generating low-margin commodities for Western formulators. The big bucks India couldn't capitalise on were in the formulation, branding, and distribution networks.

It was Dr. Wagh's unconventional thinking which unleashed a fresh narrative for this niche area. To create something that could become an indispensable entity in narrow segments he zeroed in on specific molecules where India could achieve cost leadership without impacting its quality.